Compass Minerals International Inc · NYSE · Leveraged weather-dependent commodity recovery
Hard-asset recovery trade with genuine moat, but leveraged at 8% debt cost, four net-loss years in five, and earnings that move with the weather — not the balance sheet.
## What it does Compass Minerals mines and sells highway de-icing salt (primarily from the world's largest underground rock salt mine in Goderich, Ontario, Canada) and sulfate of potash specialty fertilizer (from a solar-evaporation facility in Ogden, Utah — the largest of its kind in the Western Hemisphere). Salt is roughly 80–85% of revenues; fertilizer is the rest. Both are essential, non-substitutable inputs in their end markets.
## Making or burning money? The core cash engine is functional: operating cash flow surged from $14.4M (FY2024) to $197.7M (FY2025), confirming the underlying business generates cash when not encumbered by impairment charges. But net income has been negative in four of the last five fiscal years (FY2021: -$185.2M; FY2022: -$21.1M; FY2024: -$206.1M; FY2025: -$79.8M), and operating income only recovered to $25.3M in FY2025 after a -$116.8M collapse in FY2024. The losses were driven by two sequential write-off events — a fire-retardant business ($53M impairment) and a lithium project ($77.3M impairment/restructuring) — that are now fully wound down. The company is in recovery mode, not growth mode.
## Why it's interesting At ~$1.36B market cap with guided FY2026 adjusted EBITDA of $212–236M, the stock trades at roughly 5.7–6.4x EV/EBITDA — a meaningful discount to salt/specialty-fertilizer peers at 8–10x. The asset positions (world's largest rock salt mine, Western Hemisphere's largest SOP facility) are genuinely hard to replicate. Leverage has improved from 4.6x to 2.7x net in twelve months, and the next hard debt maturity was pushed to 2028 after redeeming $150M of 2027 notes in March 2026.
## The ONE big risk The Salt segment is 80–85% of revenues and is almost entirely weather-dependent. Three consecutive mild winters (2022–2024) drove operating income from $77.4M (FY2023) to -$116.8M (FY2024) — a $194M swing. With $650M of senior notes at 8% (roughly $52M annual interest) and a 2028 refinancing deadline, one or two weak winter seasons before the refinancing would severely compress the deleveraging path and could force expensive or dilutive remedies.
## What you'd be betting on You would be betting that winters normalize for 2–3 consecutive years, management executes the back-to-basics plan without another capital-destroying diversification, and FY2026 bid-season pricing converts the favorable low-inventory setup into realized contract gains — all simultaneously, while servicing 8% debt. That is a multi-condition bet inside a commodity business that management has already demonstrated it can mismanage.
The Salt segment (~80–85% of revenue) anchors the thesis on structural necessity: highway de-icing salt has no viable large-scale substitute for public road safety in North American winters. Demand is weather-cyclical but mean-reverting — mild winters cause inventory build, not secular destruction. Entering the FY2027 bid season, management reported system-wide inventories down 59% in volume and 47% in value year-over-year (Q2 FY2026 earnings call, May 7, 2026), a highly constructive pricing setup. K+S AG independently corroborated winter severity with a 116% YoY surge in Q1 2026 de-icing salt volumes (1.49M vs. 0.69M tonnes). The Plant Nutrition segment (SOP — sulfate of potash) serves chloride-sensitive, high-value crop agriculture and commands a $200–300/ton premium over commodity MOP potash. After the Wynyard, Saskatchewan divestiture (March 2026, $30.8M proceeds), all SOP output is concentrated at the lower-cost Ogden facility. Q2 FY2026 Plant Nutrition adjusted EBITDA reached $17M at a 25.2% margin. Both segments face structurally stable-to-growing demand; the noise is weather-cycle layered on a multi-year management-induced earnings disruption that is now behind the company.
Multi-year SEC XBRL financials (revenue & net income).
Fair-value method: EV/EBITDA applied to FY2026 guided adjusted EBITDA midpoint of $224M. Low end: 7.5x (management credibility and 2028 refinancing risk discount) yields EV ~$1.68B → equity ~$1.03B → ~$24.60/share. High end: 10x (full peer re-rating if leverage reaches 2.5x and capital returns resume) yields EV ~$2.24B → equity ~$1.59B → ~$38/share. Net debt of ~$653M uses post-March-2026 redemption figures (not FY2025 EDGAR balance sheet, which is pre-redemption). Current price ~$32.98 implies ~9x — at peer midrange, not trough.
A modeled estimate, not a price target, not advice.
Compass Minerals is a 'good pond / average fish' story with real asset moat but impaired management credibility. The Goderich, Ontario underground mine is the world's largest rock salt mine; the Ogden, Utah solar-evaporation facility is the Western Hemisphere's largest SOP producer. Both confer genuine freight-cost advantages in heavy, low-value-density commodities where logistics determine margin. The moat is real. The problem is that the company sits inside a structurally mature North American highway de-icing market, carries $713M gross debt at 8% cost after two sequential $130M+ write-off events (Fortress fire-retardant, Ogden lithium project), and is executing a back-to-basics reset whose durability depends on normal-or-better winters for 2–3 consecutive years.
| | | |---|---| | Ticker | CMP (NYSE) | | Price | $32.98 | | Market cap | ~$1.36B | | Sector | Metals & Mining / Essential Commodities | | Rating | 5.5 / 10 — Mixed | | Risk badge | YELLOW — Leveraged cyclical recovery | | Classification | Leveraged weather-dependent commodity recovery | | Gate flags | None |
---
Compass Minerals International is a North American producer of two essential industrial commodities: highway de-icing salt and sulfate of potash (SOP) specialty fertilizer.
Salt segment (~80–85% of revenue): CMP operates the Goderich, Ontario underground rock salt mine — the world's largest — plus other North American salt operations. Rock salt is sold primarily to highway departments for winter road de-icing. This is a heavy, low-value-density commodity where freight costs dominate competitive positioning; Goderich's geography gives CMP a genuine $5–10/ton freight-cost advantage in the Great Lakes/Midwest region. Competitors include Cargill Salt (which acquired International Salt in 2024), Morton Salt (owned by K+S AG), and American Rock Salt.
Plant Nutrition segment (~15–20% of revenue): CMP operates the Ogden, Utah solar-evaporation SOP facility — the Western Hemisphere's largest — producing specialty fertilizer for chloride-sensitive, high-value crops (citrus, berries, potatoes, turf). SOP commands a $200–300/ton premium over commodity muriate of potash (MOP). After selling the Wynyard, Saskatchewan SOP facility for $30.8M in March 2026, Ogden is the company's only Plant Nutrition asset.
Fortress fire-retardant (former): A magnesium-chloride-based aerial fire retardant subsidiary, fully wound down by Q2 FY2026 following USFS contract loss due to aircraft corrosion. $53M in impairment charges recognized.
Lithium (former and re-emerging as optionality): CMP invested in lithium extraction at the Great Salt Lake from at least 2021, signed a Ford supply agreement in 2023, then abandoned the project in February 2024 after $77.3M in impairment/restructuring charges. In May 2026, CMP signed a non-binding MOU with EnergyX for a 30,000 tpa DLE facility at Ogden — fully funded by EnergyX, zero capital from CMP.
---
The stated strategy is a back-to-basics reset: divest non-core assets (Wynyard done, Fortress wound down), reduce leverage toward investment-grade metrics, improve operational efficiency at Goderich (salt) and Ogden (SOP), and return cash generation to shareholders once the balance sheet allows. No dividend reinstatement guidance has been given. The EnergyX lithium MOU represents a zero-capital optionality play on the Ogden brine resource without repeating the prior capital commitment mistake.
---
| FY | Revenue | |---|---| | FY2018 | $1,493.6M | | FY2019 | $1,490.5M | | FY2020 | $1,004.9M | | FY2021 | $1,145.8M | | FY2022 | $1,245.2M | | FY2023 | $1,204.7M | | FY2024 | $1,117.4M | | FY2025 | $1,243.9M |
Revenue volatility band FY2022–FY2025: ~$128M, before operating leverage amplifies it on the income statement.
| FY | Operating income | |---|---| | FY2008 | $274.2M | | FY2014 | $311.0M | | FY2015 | $221.4M | | FY2022 | $45.4M | | FY2023 | $77.4M | | FY2024 | -$116.8M | | FY2025 | $25.3M |
Historical pre-restructuring operating income spanned a wide range: the low was $133.2M and the peak was $311.0M (FY2014). Current $25.3M represents partial recovery only.
Four of five fiscal years (FY2021 through FY2025) produced net losses: -$185.2M, -$21.1M, +$10.5M, -$206.1M, -$79.8M. Losses are impairment-driven, not purely cash-burn; operating cash flow remained functional.
| FY | OCF | |---|---| | FY2022 | $120.4M | | FY2023 | $106.0M | | FY2024 | $14.4M | | FY2025 | $197.7M |
The FY2025 OCF surge to $197.7M (from $14.4M) is the clearest evidence the underlying cash engine is intact.
| Date | Shares outstanding | |---|---| | Feb 2020 (FY2019 10-K) | 33,892,068 | | Dec 2022 (FY2022 10-K) | 41,023,332 | | Nov 2023 (FY2023 10-K) | 41,210,041 | | Dec 2024 (FY2024 10-K) | 41,452,793 | | Dec 2025 (FY2025 10-K) | 41,819,495 |
The FY2022 10-K shows a 7.1M share jump from FY2021 (34.1M) — a 20.8% dilution event in a single fiscal year, likely equity issuance during the deterioration phase. Since FY2022, share creep has been modest (~796K shares over three years) but no buyback program exists; with a suspended dividend and ongoing deleveraging, equity issuance risk remains if winters disappoint.
---
At $32.98 and ~$1.36B market cap with guided FY2026 adjusted EBITDA of $212–236M ($224M midpoint):
-
EV approximation: Market cap $1.36B + net debt ~$653M (post-redemption) ≈ $2.01B EV -
Implied EV/EBITDA: ~$2.01B / $224M ≈ 8.97x (using current EV and guided EBITDA) -
Peer range: Salt/specialty-fertilizer peers (K+S, Intrepid Potash) trade 8–10x EV/EBITDA on normalized earnings -
Management credibility discount: A 1–2 turn discount to peers is warranted given the two sequential write-off events and 2028 refinancing risk
Fair-value range: Applying 7.5x (management-discount floor, 2028 risk priced) to 9.0x (low-end peer multiple, if leverage reaches 2.5x) on $224M guided EBITDA:
Method: EV/EBITDA applied to FY2026 guided EBITDA midpoint, net debt derived from post-March-2026 redemption figures (not FY2025 EDGAR balance sheet, which pre-dates the $150M redemption). The current price at ~$33 appears to be pricing in roughly 8.9–9.0x on guidance delivery — not obviously cheap, not obviously expensive, with the risk being the guidance is weather-contingent.
Fair value low: $25 |
Fair value high: $38 |
Method: EV/EBITDA (7.5x–10x) on FY2026 guided EBITDA midpoint of $224M, management-credibility and leverage discount applied at the low end.
---
No insider ownership data or institutional concentration figures are available in the EDGAR XBRL fact sheet. Thin sell-side coverage: four analysts, all rated Buy as of Q2 FY2026 commentary, with average price target ~$31 pre-Q2 (Freedom Broker $34, Deutsche Bank $35, JPMorgan upgraded to Neutral at $30). Unanimous Buy consensus at small-caps recovering from distress reflects coverage survivor bias — bears tend to drop coverage or upgrade, leaving no adversarial counterweight in published research. Dividend suspended (0.00% yield). No buyback program.
---
CMP is a hard-asset recovery trade priced near trough multiples. The world's largest underground rock salt mine (Goderich) and Western Hemisphere's largest SOP facility (Ogden) are genuine freight-cost-advantaged positions that cannot be replicated without massive capital and multi-decade mine permitting lead times.
The cash engine is intact: FY2025 OCF of $197.7M vs. $14.4M in FY2024 is the clearest confirmation. Revenue recovered to $1,243.9M (near the FY2022 $1,245.2M peak). The two capital-destructive ventures (Fortress $53M, lithium $77.3M) are fully wound down. What remains is a focused, two-segment essential-materials business.
The bid-season setup is the best in years: inventories reportedly down 59% in volume YoY, independently corroborated by K+S AG's 116% YoY de-icing volume surge in Q1 2026. If pricing holds, FY2026 Salt EBITDA of $225–240M would confirm the operating recovery. Plant Nutrition, after the Wynyard exit, is concentrated at the higher-margin Ogden facility (25.2% EBITDA margin in Q2 FY2026).
Deleveraging is real: 4.6x to 2.7x net leverage in twelve months, 2027 notes redeemed, next maturity 2028. At $33, the stock offers the EnergyX lithium MOU as a zero-cost option on the Ogden brine resource — no capital at risk for CMP shareholders.
---
1. Chronic net losses — four of five fiscal years (EDGAR confirmed) FY2021: -$185.2M; FY2022: -$21.1M; FY2024: -$206.1M; FY2025: -$79.8M. Net income positive only in FY2023 (+$10.5M). These are impairment-driven but real: capital was destroyed, not just reclassified.
2. Sequential large write-offs — management credibility severely impaired Fortress fire-retardant: $53M in impairment charges, USFS contract lost to aircraft corrosion, subsidiary wound down. Lithium project: $77.3M impairment/restructuring, abandoned February 2024 citing Utah regulatory risk. Total: $130M+ written off in approximately 24 months. A securities class action settled for $4.9M plus governance reforms in late 2025.
3. Elevated leverage and 2028 refinancing cliff $650M in 8.0% senior notes (~$52M annual cash interest) with a hard 2028 maturity. Cash at FY2025 year-end: $59.7M (confirmed EDGAR). Net leverage 2.7x — improved but still significant for a weather-dependent business. One or two mild winters before 2028 would compress FCF, arrest deleveraging, and force refinancing in a potentially worse credit environment.
4. Extreme weather dependence — 80–85% of revenues subject to precipitation Three consecutive mild winters (2022–2024) swung operating income from $77.4M (FY2023) to -$116.8M (FY2024) — a $194M collapse. FY2025 recovery to $25.3M is partly weather normalization, not purely execution. The revenue volatility band alone (FY2022–FY2025) was ~$128M before operating leverage amplification.
5. EnergyX MOU — credibility risk from lithium re-engagement Fifteen months after writing off $77.3M on the first lithium project, management signed an MOU with EnergyX for a second attempt at the same Ogden site, subject to the same Utah regulatory regime. EnergyX is a private startup with no commercial-scale operating plant. The structure is asset-light for CMP (no capital at risk), which is better — but the pattern of narrative-first optionality engagement before regulatory conditions are validated mirrors the prior cycle. MOU is not a definitive agreement; no 8-K dated May 18, 2026 appears in the EDGAR submissions list reviewed.
6. Dividend suspended with no reinstatement guidance Yield is 0.00%. No timeline for reinstatement has been provided. Income holders who owned CMP for its historical yield have earned zero distribution through the distress period.
7. Share dilution — 20.8% in FY2022 Shares grew from 34.1M (FY2021 10-KT) to 41.0M (FY2022 10-K) in a single fiscal year. Subsequent creep is modest (~796K over FY2022–FY2025) but no buyback exists and equity issuance risk remains if weather disappoints before 2028.
8. Labor and infrastructure concentration Nearly 50% of the workforce is unionized. The Goderich mine — CMP's most important single asset — is in Ontario and is unionized. A strike during bid season or peak delivery would be catastrophic. The Ogden SOP facility relies on dike infrastructure in the Great Salt Lake basin; a 1984 dike breach required five years to recover, and Great Salt Lake water levels have been a sustained environmental concern.
9. Thin analyst coverage — no adversarial counterweight Four analysts, all Buy. Unanimous buy consensus at distressed small-caps often reflects coverage survivors, not genuine absence of risk.
---
---
CMP is a legitimate recovery story anchored on genuine, hard-to-replicate physical assets in essential-commodity markets. The underlying cash engine was never broken — FY2025 OCF of $197.7M proves that. The two write-off events (Fortress, lithium) destroyed capital and management credibility but are now fully wound down. The balance sheet is healing. The bid-season setup is constructive.
The difficulty is that at $32.98, the stock appears to be priced near a 9x EV/EBITDA on FY2026 guided earnings — which is close to the peer midrange, not a trough valuation. The significant discount to peers at the EV level reflects the leverage and management credibility discount that remains appropriate. Three things must work simultaneously over 2–3 years: normal-or-better winters, continued operational efficiency gains at Goderich, and no further capital-destroying diversification. Each individually is manageable; requiring all three simultaneously in a weather-dependent levered business with a 2028 refinancing cliff is the core investment risk.
This is not a buy-and-forget story. It is a situational recovery play where the Q3 FY2026 earnings (August 2026) will be the first real evidence of whether the bid-season pricing thesis converts to realized results.
---
*Research, not investment advice. Figures sourced from SEC filings and public data; verify before acting.*
No insider or institutional ownership data available from EDGAR XBRL fact sheet. Four sell-side analysts cover CMP, all rated Buy as of Q2 FY2026 (Freedom Broker $34 PT, Deutsche Bank $35 PT, JPMorgan Neutral $30 PT). Unanimous Buy at recovering small-caps reflects coverage survivor dynamics.
Research, rating, fair value & financials are as of the analysis on Jun 1, 2026. Generated by claude-sonnet-4-6 (pipeline). Not investment advice.